| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Amphastar Pharmaceuticals, Inc. (AMPH) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. AMPH is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.00M | $59.22M | - | |
| CFO | 177.0K | $3.49M | - | |
| VP | 172.8K | $3.41M | - | |
| VP | 122.9K | $2.43M | - | |
| Dir | 71.4K | $1.41M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 16, 2017 | Shohet Stephen B. | Director | Sale+OE | 7,862 | $18.04 | $141,861.93 | -24.6% | |
| Nov 15, 2017 | Gerst Diane G. | EVP, Qa &Regulatory Affairs | Sell | 523 | $17.77 | $9,291.57 | -1.6% | |
| Nov 9, 2017 | Shohet Stephen B. | Director | Sale+OE | 7,862 | $18.55 | $145,844.98 | -9.0% | |
| Nov 7, 2017 | Gerst Diane G. | EVP, Qa &Regulatory Affairs | Sell | 523 | $17.93 | $9,375.30 | -1.6% | |
| Nov 2, 2017 | Shohet Stephen B. | Director | Sale+OE | 7,862 | $18.37 | $144,459.53 | -24.6% | |
| Oct 26, 2017 | Shohet Stephen B. | Director | Sale+OE | 7,862 | $18.39 | $144,618.35 | -24.6% | |
| Oct 24, 2017 | Gerst Diane G. | EVP, Qa &Regulatory Affairs | Sell | 523 | $18.29 | $9,567.61 | -1.5% | |
| Oct 19, 2017 | Shohet Stephen B. | Director | Sale+OE | 7,862 | $18.34 | $144,194.58 | -24.6% | |
| Oct 17, 2017 | Gerst Diane G. | EVP, Qa &Regulatory Affairs | Sell | 523 | $18.48 | $9,664.88 | -1.5% | |
| Oct 13, 2017 | Peters William J52 | CFO, SVP &Treasurer | Sell | 3,026 | $18.56 | $56,176.48 | -3.5% |